167 related articles for article (PubMed ID: 10087681)
1. Citalopram and fluvoxamine in Tourette's disorder.
Bajo S; Battaglia M; Pegna C; Bellodi L
J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):230-1. PubMed ID: 10087681
[No Abstract] [Full Text] [Related]
2. [Severe withdrawal symptoms with fever upon stopping paroxetine].
Bakker A
Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1795; author reply 1795-6. PubMed ID: 10494333
[No Abstract] [Full Text] [Related]
3. [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine].
Rüth U; Mayer-Rosa J; Schlamp D; Freisleder FJ
Z Kinder Jugendpsychiatr Psychother; 2000 May; 28(2):105-8. PubMed ID: 10863766
[TBL] [Abstract][Full Text] [Related]
4. Complex movement disorder associated with fluvoxamine.
Bronner IM; Vanneste JA
Mov Disord; 1998 Sep; 13(5):848-50. PubMed ID: 9756160
[No Abstract] [Full Text] [Related]
5. Guanfacine for Tourette's disorder.
Fras I
J Am Acad Child Adolesc Psychiatry; 1996 Jan; 35(1):3-4. PubMed ID: 8567607
[No Abstract] [Full Text] [Related]
6. Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder.
Fennig S; Fennig SN; Pato M; Weitzman A
Br J Psychiatry; 1994 Jun; 164(6):839-41. PubMed ID: 7952995
[TBL] [Abstract][Full Text] [Related]
7. Sexual dysfunction associated with serotonin specific reuptake inhibitors.
Herrán A; Palacios-Araus L; Vázquez-Barquero JL; Díez-Manrique JF
J Clin Psychopharmacol; 1997 Feb; 17(1):67-8. PubMed ID: 9004071
[No Abstract] [Full Text] [Related]
8. Citalopram for OCD and Tourette's syndrome.
Wehr AM; Namerow LB
J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):740-1. PubMed ID: 11437010
[No Abstract] [Full Text] [Related]
9. Severe and moderate hypertriglyceridemia secondary to citalopram and fluoxetine.
Teitelbaum M
Psychosomatics; 2000; 41(5):448-9. PubMed ID: 11015636
[No Abstract] [Full Text] [Related]
10. Violent acts associated with fluvoxamine treatment.
Okada F; Okajima K
J Psychiatry Neurosci; 2001 Sep; 26(4):339-40. PubMed ID: 11590975
[No Abstract] [Full Text] [Related]
11. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder.
Delgado PL; Goodman WK; Price LH; Heninger GR; Charney DS
Br J Psychiatry; 1990 Nov; 157():762-5. PubMed ID: 2126219
[TBL] [Abstract][Full Text] [Related]
12. Unfavorable smell with citalopram?
Ghanizadeh A
J Clin Psychopharmacol; 2007 Oct; 27(5):528-9. PubMed ID: 17873697
[No Abstract] [Full Text] [Related]
13. Toxicity with selective serotonin reuptake inhibitors.
Solomons K; Gooch S; Wong A
Am J Psychiatry; 2005 Jun; 162(6):1225. PubMed ID: 15930079
[No Abstract] [Full Text] [Related]
14. A display of hypomania in a depressed male in response to fluvoxamine.
Horiguchi T; Sai S
World J Biol Psychiatry; 2001 Oct; 2(4):201-4. PubMed ID: 12587152
[TBL] [Abstract][Full Text] [Related]
15. Citalopram for impulsive aggression.
Hadi F; Franco K; Hermida T; Douton K; Zarko R
J Am Acad Child Adolesc Psychiatry; 2003 Jul; 42(7):749; author reply 749-50. PubMed ID: 12819431
[No Abstract] [Full Text] [Related]
16. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.
Goodman WK; Ward H; Kablinger A; Murphy T
J Clin Psychiatry; 1997; 58 Suppl 5():32-49. PubMed ID: 9184625
[TBL] [Abstract][Full Text] [Related]
17. Fluvoxamine for symptomatic outpatients with COVID-19.
Wu PE; Austin E; Leong D
CMAJ; 2022 Feb; 194(7):E258. PubMed ID: 35045990
[No Abstract] [Full Text] [Related]
18. [Selective serotonin reuptake inhibitors and mammary pathologies].
Shchepotin IB; Zotov AS; Dobzhenko MN
Vopr Onkol; 2010; 56(4):393-7. PubMed ID: 20968014
[No Abstract] [Full Text] [Related]
19. Citalopram, escitalopram, and the QT interval.
Med Lett Drugs Ther; 2013 Jul; 55(1421):59. PubMed ID: 23863918
[No Abstract] [Full Text] [Related]
20. SSRIs and ejaculation.
Robbins A
J Clin Psychopharmacol; 2003 Feb; 23(1):108; author reply 108-9. PubMed ID: 12544388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
